It isn't the first drug in the class to be cleared by the FDA for gMG – Argenx and UCB have FcRn blockers already on the ...

MG-ADL scores improved, indicating enhanced daily functioning for patients with myasthenia gravis. Limitations include potential coding errors, selection biases, and missing clinical data ...

A key secondary endpoint was change from baseline in Quantitative Myasthenia Gravis scale (QMG) score at week 26 in the combined patient population. Results show that patients administered Uplizna ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch. The FDA has approved the ...

Ultomiris (ravulizumab-cwvz) is a brand-name infusion prescribed for myasthenia gravis. This article covers topics such as side effects, dosage, and how Ultomiris works. Ultomiris is an ...

My name is Tasha White, and I was diagnosed with myasthenia gravis at the young age of six years old. Myasthenia gravis, or MG for short, is a chronic autoimmune disorder that causes weakness in the ...

for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive and adult patients with chronic inflammatory demyelinating ...

Here, we present the case of a 44-year-old woman with a history of myasthenia gravis (MG) who had previously undergone a thymectomy. She presented with a 20-day history of startle-induced episodes of ...

The approval applies to certain patients with myasthenia gravis or chronic inflammatory demyelinating polyneuropathy. An expert said the new option allows patients “to manage their condition ...

for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive and adult patients with chronic inflammatory demyelinating ...